Cholecalciferol supplementation does not influence β-cell function and insulin action in obese adolescents: A prospective double-blind randomized trial

Asma Javed, Adrian Vella, P. Babu Balagopal, Philip R. Fischer, Amy L. Weaver, Francesca Piccinini, Chiara Dalla Man, Claudio Cobelli, Paula D. Giesler, Jeanette M. Laugen, Seema Kumar

Research output: Contribution to journalArticle

24 Scopus citations

Abstract

Background: There is increasing interest in the extraskeletal effects of vitamin D, particularly in the obese state with regard to the development of insulin resistance and diabetes. Objective: The objective of the study was to determine the effect of 2 doses of cholecalciferol (vitamin D3) supplementation on insulin action (Si) and pancreatic β-cell function in obese adolescents. Methods: We performed a 12-wk double-blind, randomized comparison of the effect of vitamin D3 supplementation on Si and β-cell function in obese Caucasian adolescents (body mass index > 95th percentile). The subjects were randomly assigned to receive either 400 IU/d (n = 25) or 2000 IU/d (n = 26) of vitamin D3. Each subject underwent a 7-sample 75 g oral glucose tolerance test, with glucose, insulin, and C-peptide measurements, to calculate Si and β-cell function as assessed by the disposition index (DI), with use of the oral minimal model before and after supplementation. A total of 51 subjects aged 15.0 ± 1.9 y were enrolled. Included for analysis at follow-up were a total of 46 subjects (20 male and 26 female adolescents), 23 in each group. Results: Initial serum 25-hydroxyvitamin D [25(OH)D] was 24.0 ± 8.1μg/L. There was no correlation between 25(OH)D concentrations and Si or DI. There was a modest but significant increase in 25(OH)D concentration in the 2000 IU/d group (3.1 ± 6.5 μg/L, P = 0.04) but not in the 400 IU/d group (P = 0.39). There was no change in Si or DI following vitamin D3 supplementation in either of the treatment groups (all P > 0.10). Conclusions: The current study shows no effect from vitamin D3 supplementation, irrespective of its dose, on β-cell function or insulin action in obese nondiabetic adolescents with relatively good vitamin D status. Whether obese adolescents with vitamin D deficiency and impaired glucose metabolism would respond differently to vitamin D3 supplementation remains unclear and warrants further studies.

Original languageEnglish (US)
Pages (from-to)284-290
Number of pages7
JournalJournal of Nutrition
Volume145
Issue number2
DOIs
StatePublished - 2015

    Fingerprint

Keywords

  • Disposition index
  • Insulin action
  • Insulin secretion
  • Obese adolescents
  • Vitamin D supplementation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Javed, A., Vella, A., Babu Balagopal, P., Fischer, P. R., Weaver, A. L., Piccinini, F., Man, C. D., Cobelli, C., Giesler, P. D., Laugen, J. M., & Kumar, S. (2015). Cholecalciferol supplementation does not influence β-cell function and insulin action in obese adolescents: A prospective double-blind randomized trial. Journal of Nutrition, 145(2), 284-290. https://doi.org/10.3945/jn.114.202010